Literature DB >> 21045595

Toward a comprehensive approach to HIV prevention for people who use drugs.

Brandon D L Marshall1, Evan Wood.   

Abstract

Comprehensive HIV prevention interventions are increasingly recognized as critical in the global effort to reduce HIV transmission among people who use injection drugs. Scientific evidence clearly shows that a variety of biomedical, behavioral, and structural interventions can prevent and reduce injection drug user-driven HIV epidemics, yet social and structural barriers to their implementation remain. This review discusses the scientific evidence on the effectiveness of individual programs for reducing HIV incidence among people who use injection drugs and how, by integrating individual programs as complements within a comprehensive HIV prevention approach, it is possible to achieve, and to sustain, greater results than those of individual programs alone. The article concludes with a discussion of a critical research priority; namely, to improve the implementation of comprehensive HIV prevention interventions in settings of prevalent injection drug use and to overcome the often complex barriers that impede them. Such an effort will require more than research alone, however. It will also require the ongoing commitment of policymakers, public health officials, and the affected communities themselves to use comprehensive HIV treatment and prevention as the most effective strategy to reduce new HIV infections.

Entities:  

Mesh:

Year:  2010        PMID: 21045595      PMCID: PMC3074530          DOI: 10.1097/QAI.0b013e3181f9c203

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  54 in total

1.  Incarceration and risk for HIV infection among injection drug users in Bangkok.

Authors:  Kachit Choopanya; Don C Des Jarlais; Suphak Vanichseni; Dwip Kitayaporn; Philip A Mock; Suwanee Raktham; Krit Hireanras; William L Heyward; Sathit Sujarita; Timothy D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

Review 2.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

3.  Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.

Authors:  Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

Review 4.  Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.

Authors:  Alex Wodak; Annie Cooney
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

5.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 6.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 7.  HIV prevention for injecting drug users: the first 25 years and counting.

Authors:  Don C Des Jarlais; Salaam Semaan
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

8.  Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users.

Authors:  Carl A Latkin; Valerie Forman; Amy Knowlton; Susan Sherman
Journal:  Soc Sci Med       Date:  2003-02       Impact factor: 4.634

9.  Incarceration and drug use patterns among a cohort of injection drug users.

Authors:  Kora DeBeck; Thomas Kerr; Kathy Li; M-J Milloy; Julio Montaner; Evan Wood
Journal:  Addiction       Date:  2009-01       Impact factor: 6.526

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  9 in total

Review 1.  HIV Self-Testing: a Review of Current Implementation and Fidelity.

Authors:  Kristecia S Estem; Joseph Catania; Jeffrey D Klausner
Journal:  Curr HIV/AIDS Rep       Date:  2016-04       Impact factor: 5.071

2.  Prevention and treatment of HIV/AIDS among drug-using populations: a global perspective.

Authors:  Elizabeth Y Lambert; Jacques L Normand; Nora D Volkow
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 3.  Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.

Authors:  E Jennifer Edelman; David A Fiellin
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

4.  Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?

Authors:  Jill E Pace; George K Siberry; Rohan Hazra; Bill G Kapogiannis
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

5.  The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.

Authors:  E Jennifer Edelman; Tongtan Chantarat; Sarah Caffrey; Amina Chaudhry; Patrick G O'Connor; Linda Weiss; David A Fiellin; Lynn E Fiellin
Journal:  Drug Alcohol Depend       Date:  2014-03-15       Impact factor: 4.492

6.  Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.

Authors:  Lauren Gooden; Lisa R Metsch; Margaret R Pereyra; C Kevin Malotte; Louise F Haynes; Antoine Douaihy; Jack Chally; Raul N Mandler; Daniel J Feaster
Journal:  AIDS Behav       Date:  2016-09

7.  Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study.

Authors:  Mary E Mackesy-Amiti; Lorna Finnegan; Lawrence J Ouellet; Elizabeth T Golub; Holly Hagan; Sharon M Hudson; Mary H Latka; Richard S Garfein
Journal:  AIDS Behav       Date:  2013-07

8.  Effects of combination approach on harm reduction programs: the Taiwan experience.

Authors:  Ting Lin; Chang-Hsun Chen; Pesus Chou
Journal:  Harm Reduct J       Date:  2016-07-04

9.  Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.

Authors:  Cora L Bernard; Isabelle J Rao; Konner K Robison; Margaret L Brandeau
Journal:  PLoS Med       Date:  2020-10-13       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.